XML 65 R53.htm IDEA: XBRL DOCUMENT v3.19.2
New Business (Narrative) (Details)
$ / shares in Units, $ in Thousands
6 Months Ended
Mar. 22, 2019
USD ($)
$ / shares
shares
May 16, 2018
USD ($)
Jun. 30, 2019
USD ($)
$ / shares
entity
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Common Stock, par value     $ 0.01 $ 0.01
Common Stock, shares issued | shares     1,217,624 1,204,196
Common Stock, shares outstanding | shares     1,217,624 1,204,196
Number of entities used for investment in private offering | entity     2  
Investments Measured At NAV [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Net asset value | $ [1]     $ 2,275 $ 4,050
U.S. Insurance JV [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Required investment percentage of total equity   4.50%    
U.S. Insurance JV [Member] | Maximum [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Net asset value | $   $ 3,000    
U.S. Insurance JV [Member] | Investor [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Net asset value | $   $ 63,000    
SPAC Fund [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Net asset value | $     $ 630  
Insurance SPAC [Member] | IPO [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Sale of Stock, Number of Shares Issued in Transaction | shares 15,065,000      
Common Stock, par value $ 0.0001      
Sale of Stock, Price Per Share $ 10.00      
Sale of Stock, Consideration Received on Transaction | $ $ 150,650      
Option period 45 days      
Sale of Stock, Number Of Shares For Additional Purchase | shares 1,965,000      
Common Stock, shares issued | shares 20,653,333      
Common Stock, shares outstanding | shares 20,653,333      
Insurance SPAC [Member] | IPO [Member] | SPAC Warrant [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 11.50      
Sponsor Entities [Member] | Insurance SPAC [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Period Of Required Business Combination To Occur Following IPO For Proceeds To Not Expire     18 months  
Investment Owned, Balance, Shares | shares     5,103,333  
Period Shares Held From Private Placement Will Not Be Transferable Or Salable     30 days  
Exception Percentage Of Total Shares That Can Be Transferable Or Salable     20.00%  
Period Out Of Consecutive 30 Trading Days For Transferable Or Salable Price Tranches To Hit     20 days  
Sponsor Entities [Member] | Insurance SPAC [Member] | Closing Price Tranche 1 [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Sale of Stock, Price Per Share     $ 12.00  
Sponsor Entities [Member] | Insurance SPAC [Member] | Closing Price Tranche 2 [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Sale of Stock, Price Per Share     13.50  
Sponsor Entities [Member] | Insurance SPAC [Member] | Closing Price Tranche 3 [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Sale of Stock, Price Per Share     15.00  
Sponsor Entities [Member] | Insurance SPAC [Member] | Closing Price Tranche 4 [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Sale of Stock, Price Per Share     $ 17.00  
Sponsor Entities [Member] | Insurance SPAC [Member] | Private Placement [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Sale of Stock, Number of Shares Issued in Transaction | shares     375,000  
Sale of Stock, Price Per Share     $ 10.00  
Sale of Stock, Consideration Received on Transaction | $     $ 3,750  
Period Of Private Placement Shares Not To Be Transferable, Assignable, Or Salable     30 days  
Sponsor Entities [Member] | Insurance SPAC [Member] | Private Placement [Member] | Maximum [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Period Of Private Placement Share Not Exercisable     5 years  
Sponsor Entities [Member] | Insurance SPAC [Member] | Investor [Member]        
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]        
Net asset value | $     $ 2,550  
[1] As a practical expedient, the Company uses NAV or its equivalent to measure the fair value of its investments in EuroDekania, the U.S. Insurance JV, and the SPAC Fund. EuroDekania invests in hybrid capital securities of European companies. The U.S. Insurance JV invests in debt issued by small and medium sized U.S. and Bermuda insurance and reinsurance companies. The SPAC Fund invests in equity securities of SPACs. According to ASC 820, these investments are not categorized within the valuation hierarchy.